Firm News
Oblon Helps Improve Children's Lives Through Better Vision
The Essilor Vision Foundation hopes to eradicate poor vision from the world by 2050; Oblon donates again to support that cause. Good vision is a basic human right, with this donation the EVF will be able to provide vision care to people living below the poverty line in over 40 countries. They dedicate significant resources worldwide to enable children to perform better at school, as well as improve the visual health of other disadvantaged communities.
Firm News
Eleven Oblon Attorneys Recognized as Best Lawyers 2020
Eleven Oblon attorneys have been named to the 2020 edition of Best Lawyers in America.
In The News
USPTO Proposes Patent Fee Adjustments
On July 31, 2019, the USPTO announced on its Director's Forum blog the issuance of a notice of proposed rulemaking (NPRM) to adjust certain patent fees as authorized by the AIA. A 60-day public comment period, ending on September 30, 2019, is now open. The proposed adjustments – which number nearly 200 and include filing, search, examination, maintenance, and trial and appeal fees, for example – are summarized in a Table on the USPTO's Fee Setting and Adjusting webpage.
Non-Limiting Clauses and Written Description Based on Substantially Equivalent Disclosure
Nalpropion Pharmaceuticals, Inc. v Actavis Laboratories FL, Inc (Fed. Cir. Aug. 15, 2019) is a precedential opinion written by Judge Lourie with Judge Wallach and a dissent from Judge Prost in a case centered on an ANDA litigation in which Actavis sought approval for their generic version to Nalpropion's patents for the Contrave® product. Footnote 1 in the opinion outlines the rather complex history of the ownership/license interests as they changed over time.
Argument with Emphasis on "Particular" Combination of Salts Invoked Prosecution History Estoppel
More"Tips for Safeguarding Your Products from Fakes"
Derek Mason was interviewed by Michael Keating for a blog post entitled "Tips for Safeguarding Your Products from Fakes," featured in Industrial Equipment News (IEN).
AIPLA on the Road: Latest on Patent Practice Board Before the USPTO and the PTAB - Alexandria
Todd Baker will be a panelist at the "AIPLA on the Road: Latest on Patent Practice Board Before the USPTO and the PTAB - Alexandria" event, at the USPTO on August 27th, 2019.
Privilege in IP Litigation: Overcoming Challenges in Review, Applicability to Foreign Attorneys, Disclosure
Jeff McIntyre will participate in a CLE webinar panel, hosted by Strafford on September 12, entitled: Privilege in IP Litigation: Overcoming Challenges in Review, Applicability to Foreign Attorneys, Disclosure.
2019 AIPPI World Congress
Rob Mattson and Norman Oblon are attending the 2019 AIPPI World Congress conference in London, from September 15-18th. The International Association for the Protection of Intellectual Property, known as the AIPPI (Association Internationale pour la Protection de la Propriété Intellectuelle), is the world's leading International Organization dedicated to the development and the improvement of laws for the protection of intellectual property.
Eleven Oblon Attorneys Recognized as Best Lawyers 2020
Eleven Oblon attorneys have been named to the 2020 edition of Best Lawyers in America.
Oblon Launches Life Sciences Blog
Today, Oblon launched its Life Sciences blog, www.lifesciencesipblog.com , which is designed to report and comment on Intellectual property matters related to the life sciences industry.
Oblon Again Ranked in Legal 500
Oblon was recognized by The Legal 500 as one of the America's leading firms in Patent Prosecution, Re-Examination and Post Grant Proceedings for the 11th straight year.
Twitter Feed
Tweets by @Oblon_IPLibrary
Industries
Chemicals
- Agrochemicals
- Biotechnology
- Metallurgy
- Polymers
- Small Molecules
Electronics & Software
- Electronics & Semiconductors
- Software
- Wireless & Telecom
- Industry Standards
Heavy Industry
- Agricultural Machinery
- Industrial Robots
- Transportation
Consumer Products
- Apparel
- Packaging
- Sporting Goods
Life Sciences
- Biotechnology
- Medical Devices
- Pharmaceuticals
Energy & Renewables
- Renewable Energy
- Petrochemicals
Find a Person
Showing 3 of 10